{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T21:20:19Z","timestamp":1694640019664},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,8,19]],"date-time":"2010-08-19T00:00:00Z","timestamp":1282176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiologe"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s00117-010-2000-2","type":"journal-article","created":{"date-parts":[[2010,8,17]],"date-time":"2010-08-17T21:04:15Z","timestamp":1282079055000},"page":"846-854","source":"Crossref","is-referenced-by-count":0,"title":["Klassifikation und leitliniengerechte Empfehlungen zur Diagnose und Therapie von Vaskulitiden","Classification and therapy of vasculitis according to recommendations of the European League Against Rheumatism (EULAR)"],"prefix":"10.1007","volume":"50","author":[{"given":"J.U.","family":"Holle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Bley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.L.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,19]]},"reference":[{"key":"2000_CR1","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1002\/art.23699","volume":"58","author":"Bley","year":"2008","unstructured":"Bley T, Reinhard M, Hauenstein C et al (2008) Comparison of duplex sonography and high-resolution mangetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum 58:2574\u20132578","journal-title":"Arthritis Rheum"},{"key":"2000_CR2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/art.21699","volume":"55","author":"Blockmans","year":"2006","unstructured":"Blockmans D, Ceuninck L de, Vanderschueren S et al (2006) Repetitive 18-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study on 35 patients. Arthritis Rheum 55:131\u2013137","journal-title":"Arthritis Rheum"},{"key":"2000_CR3","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/rheumatology\/ken119","volume":"47","author":"Blockmans","year":"2008","unstructured":"Blockmans D, Coudyzer W, Vanderschueren S et al (2008) Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology 47:1179\u20131184","journal-title":"Rheumatology"},{"key":"2000_CR4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2214\/ajr.175.2.1750505","volume":"175","author":"Choe","year":"2000","unstructured":"Choe YH, Han BK, Koh EM et al (2000) Takayasu arteritis: assessment of disease activity with contrast-enhanced MR imaging. Am J Roentgenol 175:505\u2013511","journal-title":"Am J Roentgenol"},{"key":"2000_CR5","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","volume":"150","author":"De","year":"2009","unstructured":"De Groot K, Harper L, Jayne DR et al (2009) Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med 150:670\u2013680","journal-title":"Ann Intern Med"},{"key":"2000_CR6","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","volume":"52","author":"De","year":"2005","unstructured":"De Groot K, Rasmussen N, Bacon PA et al (2005) Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 52(8):2461\u20132469","journal-title":"Arthritis Rheum"},{"key":"2000_CR7","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","volume":"87","author":"Falk","year":"1990","unstructured":"Falk RJ, Terrell RS, Charles LA et al (1990) Anti-neutrophil cytoplasmatic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 87:4115\u20134119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2000_CR8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/01.bor.0000198002.42826.c2","volume":"18","author":"Ferri","year":"2006","unstructured":"Ferri C, Mascia MT (2006) Cryoglobulinemic vasculitis. Curr Opin Rheumatol 18:54\u201363","journal-title":"Curr Opin Rheumatol"},{"key":"2000_CR9","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/art.1780330812","volume":"33","author":"Fries","year":"1990","unstructured":"Fries JF, Hunder GG, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum 33:1135\u20131136","journal-title":"Arthritis Rheum"},{"key":"2000_CR10","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.2006.062711","volume":"66","author":"Hellmich","year":"2007","unstructured":"Hellmich B, Flossman O, Gross WL et al (2007) EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 66:605\u2013617","journal-title":"Ann Rheum Dis"},{"key":"2000_CR11","doi-asserted-by":"crossref","unstructured":"Holle JU, Gross WL (2009). ANCA-associated vasculitides: pathogenetic aspects and current evidence-based therapy. J Autoimmun 32(3\u20134):163\u2013171","DOI":"10.1016\/j.jaut.2009.02.019"},{"key":"2000_CR12","doi-asserted-by":"crossref","unstructured":"Holle JU, Gross WL, Holl-Ulrich K et al (2010) Prospective long-term follow-up of localized Wegener granulomatosis: does it occur as persistent disease stage? Ann Rheum Dis [Epub ahead of print]","DOI":"10.1136\/ard.2010.130203"},{"key":"2000_CR13","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","volume":"18","author":"Jayne","year":"2007","unstructured":"Jayne DR, Gaskin G, Rasmussen N et al (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18(7):2180\u20132188","journal-title":"J Am Soc Nephrol"},{"key":"2000_CR14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/qjmed\/93.7.433","volume":"93","author":"Jayne","year":"2000","unstructured":"Jayne DR, Chapel H, Adu D et al (2000) Intravenous immunoglobulin for ANCA-asscociated systemic vasculitis with persistent disease activity. QJM 93(7):433\u2013439","journal-title":"QJM"},{"key":"2000_CR15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"Jennette","year":"1994","unstructured":"Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37(2):187\u2013192","journal-title":"Arthritis Rheum"},{"key":"2000_CR16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","volume":"363","author":"Jones","year":"2010","unstructured":"Jones R, Cohen-Tervaert JW, Hauser T et al (2010) Rituximab vs. cyclophosphamide in ANCA-associated vasculitis. N Engl J Med 363:211\u2013220","journal-title":"N Engl J Med"},{"key":"2000_CR17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.7326\/0003-4819-142-5-200503010-00011","volume":"142","author":"Karassa","year":"2005","unstructured":"Karassa FB, Matsagas MI, Schmidt WA et al (2005) Meta-analysis: test performance of ultrasonography for giant cell arteritis. Ann Intern Med 142:359\u2013369","journal-title":"Ann Intern Med"},{"key":"2000_CR18","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1053\/j.ajkd.2003.08.015","volume":"42","author":"Klemmer","year":"2003","unstructured":"Klemmer PJ, Chalermskulrat W, Reif MS et al (2003) Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis 42(6):1149\u20131153","journal-title":"Am J Kidney Dis"},{"key":"2000_CR19","first-page":"671","volume":"87","author":"Luqmani","year":"1994","unstructured":"Luqmani RA, Bacon PA, Moots RJ et al (1994) Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 87:671\u2013681","journal-title":"QJM"},{"key":"2000_CR20","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/art.22754","volume":"56","author":"Mahr","year":"2007","unstructured":"Mahr AD, Jover JA, Spiera RF et al (2007) Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum 56:2789\u20132797","journal-title":"Arthritis Rheum"},{"key":"2000_CR21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/ard.2007.082115","volume":"67","author":"Martinez-Taboada","year":"2008","unstructured":"Martinez-Taboada VM, Rodriguez-Valverde V, Carreno L et al (2008) A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects. Ann Rheum Dis 67:625\u2013630","journal-title":"Ann Rheum Dis"},{"key":"2000_CR22","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1002\/art.22163","volume":"54","author":"Mazlumzadeh","year":"2006","unstructured":"Mazlumzadeh M, Hunder GG, Easley KA et al (2006) Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum 54:3310\u20133318","journal-title":"Arthritis Rheum"},{"key":"2000_CR23","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/ard.2003.011692","volume":"63","author":"Moosig","year":"2004","unstructured":"Moosig F, Czech N, Mehrl C et al (2004) Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatic: a quantitive PET study. Ann Rheum Dis 63:870\u2013873","journal-title":"Ann Rheum Dis"},{"key":"2000_CR24","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","volume":"68","author":"Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Guillevin L, Cid MC et al (2009) EULAR recommendations for the management of primary small vessel vasculitis. Ann Rheum Dis 68:310\u2013317","journal-title":"Ann Rheum Dis"},{"key":"2000_CR25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semarthrit.2006.12.005","volume":"37","author":"Narvaez","year":"2007","unstructured":"Narvaez J, Bernad B, Roig-Vilaseca D et al (2007) Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis. Semin Arthritis Rheum 37:13\u201319","journal-title":"Semin Arthritis Rheum"},{"key":"2000_CR26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/rheumatology\/keh513","volume":"44","author":"Narvaez","year":"2005","unstructured":"Narvaez J, Narvaez JA, Nolla JM et al (2005) Giant cell arteritis and polymyalgia rheumatic: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis. J Rheumatol 44:479\u2013483","journal-title":"J Rheumatol"},{"key":"2000_CR27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/BOR.0b013e328333390b","volume":"22","author":"Pagnoux","year":"2010","unstructured":"Pagnoux C, Guillevin (2010) Churg-Strauss syndrome: evidence for disease subtypes? Curr Opin Rheumatol 22:21\u201328","journal-title":"Curr Opin Rheumatol"},{"key":"2000_CR28","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","volume":"359","author":"Pagnoux","year":"2008","unstructured":"Pagnoux C, Mahr A, Hamidou MA et al (2008) Azathioprine of methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med 359:2790\u20132803","journal-title":"N Engl J Med"},{"key":"2000_CR29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2249.1995.tb06161.x","volume":"101","author":"Rasmussen","year":"1995","unstructured":"Rasmussen N, Jayne RWD, Abramowicz D et al (1995) European therapeutic trials in ANCA-associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials. Clin Exp Immunol 101 (suppl 1):29\u201334","journal-title":"Clin Exp Immunol"},{"key":"2000_CR30","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1309\/WAEPADW0K4LPUHFN","volume":"120","author":"Savige","year":"2003","unstructured":"Savige J, Dimech W, Fritzler M et al (2003) Addendum to the International Consensus Statement on testing and reporting of anti-neutrophil cytoplasmatic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. Am J Clin Pathol 120:312\u2013314","journal-title":"Am J Clin Pathol"},{"key":"2000_CR31","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1136\/ard.2003.015651","volume":"63","author":"Scheef","year":"2004","unstructured":"Scheef AK, Meeler J, Vosshenrich R et al (2004) Diagnosis and follow-up of aortitis on the elderly. Ann Rheum Dis 63:1507\u20131510","journal-title":"Ann Rheum Dis"},{"key":"2000_CR32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/BOR.0b013e328011cb6f","volume":"19","author":"Segelmark","year":"2007","unstructured":"Segelmark M, Selga D (2007) The challenge of managing patients with polyarteritis nodosa. Curr Opin Rheumatol 19:33\u201338","journal-title":"Curr Opin Rheumatol"},{"key":"2000_CR33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1148\/radiographics.21.1.g01ja16151","volume":"21","author":"Stanson","year":"2001","unstructured":"Stanson AW, Friese JL, Johnson CM et al (2001) Polyarteritis nodosa: spectrum of angiographic findings. Radiographics 21:151\u2013159","journal-title":"Radiographics"},{"key":"2000_CR34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"Stone","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R et al (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363:221\u2013232","journal-title":"N Engl J Med"},{"key":"2000_CR35","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/art.10251","volume":"46","author":"Tso","year":"2002","unstructured":"Tso E, Flamm SD, White RD et al (2002) Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum 46:1634\u20131642","journal-title":"Arthritis Rheum"},{"key":"2000_CR36","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","volume":"66","author":"Watts","year":"2007","unstructured":"Watts R, Lane S, Hanslik T et al (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222\u2013227","journal-title":"Ann Rheum Dis"}],"container-title":["Der Radiologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-010-2000-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00117-010-2000-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-010-2000-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T08:48:24Z","timestamp":1636188504000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00117-010-2000-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,19]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["2000"],"URL":"https:\/\/doi.org\/10.1007\/s00117-010-2000-2","relation":{},"ISSN":["0033-832X","1432-2102"],"issn-type":[{"value":"0033-832X","type":"print"},{"value":"1432-2102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,19]]}}}